Insider Buying: INOVIQ (ASX:IIQ) Insider Purchases 100,000 Shares of Stock

INOVIQ Ltd (ASX:IIQ) insider Peter Gunzburg purchased 100,000 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was bought at an average cost of A$0.33 per share, for a total transaction of A$33,000.00.

INOVIQ Price Performance

The stock has a market capitalization of $47.40 million, a PE ratio of -6.02 and a beta of 2.04. The company has a debt-to-equity ratio of 2.02, a current ratio of 7.07 and a quick ratio of 9.52.

INOVIQ Company Profile

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers.